Stockreport

PAVmed Non-GAAP EPS of -$0.99 beats by $0.56, revenue of $1.01M misses by $0.03M [Seeking Alpha]

PAVmed Inc.  (PAVM) 
US:NASDAQ Investor Relations: ir.pavm.com
PDF PAVmed had cash and cash equivalents of $25.5 million as of March 31, 2024, compared to $19.6 million as of December 31, 2023. Recommended For You More Trending News [Read more]